The General Court of the European Union has issued a temporary injunction requiring the European Medicines Agency to keep information from two drug companies confidential, a blow to the agency's efforts to share clinical and nonclinical data extensively. The Pharmaceutical Research and Manufacturers of America praised the decision. "Biopharmaceutical companies support responsible data sharing that protects patient privacy, maintains the integrity of the regulatory review process, and preserves incentives for biomedical research," PhRMA Senior Vice President Matthew Bennett said. "Unfortunately, the EMA's current and proposed policies fail to respect these principles."
Published in Brief: